ADVFN Logo ADVFN

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

CVS CVS Health CDR

11.08
0.10 (0.91%)
27 Dec 2024 - Closed
Realtime Data
Name Symbol Market Type
CVS Health CDR NEO:CVS NEO Depository Receipt
  Price Change % Change Price Bid Price Offer Price High Price Low Price Open Price Traded Last Trade
  0.10 0.91% 11.08 10.70 11.20 11.19 11.00 11.09 21,210 22:30:01

Express Scripts Executive: Co Will Keep Weighing Opportunities

09/09/2009 9:26pm

Dow Jones News


CVS Health CDR (NEO:CVS)
Historical Stock Chart


From Dec 2019 to Dec 2024

Click Here for more CVS Health CDR Charts.

Express Scripts Inc. (ESRX), working toward closing its planned purchase of health insurer WellPoint Inc.'s (WLP) in-house pharmacy benefits management, or PBM, operation, won't stop considering other potential acquisitions.

"We'll continue to look at opportunities at the right price and the right circumstances," David Myers, Express Scripts' vice president for investor relations, said Wednesday at the Thomas Weisel Partners Healthcare Conference.

The St. Louis pharmacy benefits manager, the third-largest in the market, will expand significantly once it completes its nearly $4.7 billion acquisition of WellPoint's NextRx subsidiaries. Express Scripts expects the deal to close in the fourth quarter.

After WellPoint and Express Scripts announced their transaction, which includes a 10-year contract for Express Scripts to provide services to WellPoint, the market turned its attention to the potential for other health insurers to divest their in-house PBMs.

Cigna Corp. (CI) has indicated an interest in placing its PBM for sale, and The Wall Street Journal reported that Aetna Inc. (AET) has put its drug-benefits business on the block.

Medco Health Solutions Inc. (MHS), one of the largest PBMs, is in a good position and will be opportunistic in terms of acquisitions, its chief executive said a few weeks ago. A spokeswoman for retail drug store-PBM hybrid CVS Caremark Corp. (CVS) said last week the company doesn't comment on rumors related to potential mergers and acquisitions.

Express Scripts shares recently rose 80 cents, or 1.1%, to $74.74.

-By Dinah Wisenberg Brin, Dow Jones Newswires; 215-656-8285; dinah.brin@dowjones.com

 
 

1 Year CVS Health CDR Chart

1 Year CVS Health CDR Chart

1 Month CVS Health CDR Chart

1 Month CVS Health CDR Chart

Your Recent History

Delayed Upgrade Clock